ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES, 25 MG / 200 MG
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ASPIRIN AND EXTENDED-RELEASE DIPYRIDAMOLE CAPSULES, 25 MG / 200 MG, covering 2017-01-18 to 2026-08-05. Get the full timeline:
Most recent: FDA Approved: ASPIRIN AND EXTENDED - RELEASE DIPYRIDAMOLE CAPSULES, 25 MG / 200 MG — Supplemental Application (Par Health USA, LLC)